Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04332783 · ClinicalTrials.gov registry record · NA

Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search

A NA study of Vision, sponsored by University of California, Berkeley.

Recruiting
Registry status
NA
Development phase
10,120
Enrollment target
1
Study location

NCT04332783 is a NA study of Vision that is actively recruiting participants, run by University of California, Berkeley. The registered enrollment target is 10,120 participants, above the 70-participant average among 5 other Vision trials with a reported enrollment target (14357% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04332783, a NA study of Vision, is actively recruiting participants, sponsored by University of California, Berkeley.

RECRUITING
Registry status
NA
Development phase
10,120 participants
Enrollment target
1
Study location

Study Summary

Remote-store-and-forward teledermatology has recently grown exponentially in popularity and use as an efficient, accurate, and cost-effective way to improve the health and well-being of countless patients. Despite advances in machine learning and computer vision, the screening and reading of dermatological images still depends on the visual system of human observers (e.g., clinicians), who receive extensive training to best recognize lesions and anomalies. In remote store-and-forward teledermatology settings, clinicians may examine hundreds of images on a daily basis, seeing several images one after the other. A main underlying assumption of their work is that clinician percepts and decisions about a current image are completely independent from prior viewings. However, we and other groups demonstrated that the visual system has visual serial dependencies (VSDs) at many levels, from perception to decision making, including in clinical tasks. These sequential dependencies, replicated hundreds of times in the literature, mean that what was seen in the past influences (and captures) what is seen and reported at this moment. Theoretically, VSDs are helpful in an autocorrelated natural world, but they are suboptimal in visual tasks conducted in artificial situations where images are not always related. Importantly, serial dependencies in perceptual processing could thus produce significant errors during diagnostic judgments of dermatological images. Our central hypothesis is that VSD can have a disruptive effect in asynchronous remote-store-and-forward teledermatology judgments that impairs accurate detection and recognition of lesions. This hypothesis is supported by our robust pilot data, which show that VSD strongly biases lesion classification in both untrained observers and expert clinicians. The rationale for the proposed research projects is that once it is known how serial dependence arises and how it impacts judgments, we can understand how to control for it. He

Conditions Studied

Interventions

  • BEHAVIORAL psychophysics of sequential biases (no drug or patient work)

Study Locations (1)

California

  • University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 10,120 participants
Start Date 2019-04-01
Est. Completion 2032-10-30
Phase NA

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT04332783

The ClinicalTrials.gov registry entry for NCT04332783 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10,120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 70-participant average among 5 other Vision trials with a reported enrollment target (14357% higher). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vision appearing as the primary indexed condition, and to 1 intervention - of which psychophysics of sequential biases (no drug or patient work) is the first listed.

NCT04332783 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04332783 about?

NCT04332783 is a clinical study titled "Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search". Remote-store-and-forward teledermatology has recently grown exponentially in popularity and use as an efficient, accurate, and cost-effective way to improve the health and well-being of countless patients. Despite advances in machine learning and computer vision, the screening and reading of dermato...

What is the current status of trial NCT04332783?

This trial is currently recruiting. It is a NA study. The enrollment target is 10,120 participants. The study started on 2019-04-01. Estimated completion is 2032-10-30.

What conditions does trial NCT04332783 study?

This clinical trial studies the following conditions: Vision.

What interventions are being tested in trial NCT04332783?

The interventions under investigation include: psychophysics of sequential biases (no drug or patient work) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04332783?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04332783 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.